On March 7, Calumet Specialty Products (CLMT) reported its 4th quarter 2018 results and held a conference call. The company reported an EBITDA number of almost $110 million pro forma capturing the attention of investors and analysts. The extraordinary high EBITDA reflects on the company's ability to produce the financial health required to begin paying a dividend at some future date. We are reviewing the 4th quarter results from which a cash flow and adjusted EBITDA estimate for 1st quarter and the coming year were derived.
"I'm pleased to report that Calumet produced